Results 31 to 40 of about 136,879 (260)

Classical and Delayed Orthostatic Hypotension in Patients With Unexplained Syncope and Severe Orthostatic Intolerance

open access: yesFrontiers in Cardiovascular Medicine, 2020
Background: Orthostatic hypotension (OH) is a major sign of cardiovascular autonomic failure leading to orthostatic intolerance and syncope. Orthostatic hypotension is traditionally divided into classical OH (cOH) and delayed OH (dOH), but the ...
P. Torabi   +4 more
semanticscholar   +1 more source

Management of Orthostatic Hypotension in Parkinson’s Disease

open access: yesJournal of Parkinson's Disease, 2020
Orthostatic hypotension (OH) is a common non-motor feature of Parkinson’s disease that may cause unexplained falls, syncope, lightheadedness, cognitive impairment, dyspnea, fatigue, blurred vision, shoulder, neck, or low-back pain upon standing.
A. Fanciulli   +4 more
semanticscholar   +1 more source

Postural changes in optic nerve and optic nerve sheath diameters in postural orthostatic tachycardia syndrome and spontaneous intracranial hypotension: A cohort study.

open access: yesPLoS ONE, 2019
BackgroundPostural orthostatic tachycardia syndrome is a disorder of the autonomic nervous system. Approximately 30% of patients experience orthostatic headaches.
Debora Cipriani   +8 more
doaj   +1 more source

Relationship between sarcopenia and orthostatic hypotension.

open access: yesAge and Ageing, 2020
BACKGROUND The relationship between sarcopenia and orthostatic hypotension (OH) is unclear. OBJECTIVES The aim of the present study was to investigate associations between sarcopenia/sarcopenia severity and OH.
P. Soysal   +5 more
semanticscholar   +1 more source

Squamous Carcinoma of the Lung Presenting as Migraine-Type Headache: A Case Report

open access: yesCase Reports in Oncology, 2015
Introduction: Orthostatic hypotension has long been recognised as a paraneoplastic effect of lung cancer. Lung cancer presenting with orthostatic hypotension and migraine-type headaches has not been previously described in the literature.
Eswaran Waran
doaj   +1 more source

Fludrocortisone for orthostatic hypotension

open access: yesCochrane Database of Systematic Reviews, 2017
Orthostatic hypotension is an excessive fall in blood pressure (BP) while standing and is the result of a decrease in cardiac output or defective or inadequate vasoconstrictor mechanisms. Fludrocortisone is a mineralocorticoid that increases blood volume and blood pressure. Fludrocortisone is considered the first- or second-line pharmacological therapy
Stephanie Veazie   +6 more
openaire   +4 more sources

Association of transient orthostatic hypotension with falls and syncope in patients with Parkinson disease

open access: yesNeurology, 2020
Objectives To assess the frequency of transient orthostatic hypotension (tOH) and its clinical impact in Parkinson disease (PD), we retrospectively studied 173 patients with PD and 173 age- and sex-matched controls with orthostatic intolerance, who ...
A. Fanciulli   +12 more
semanticscholar   +1 more source

Orthostatic hypotension: An overlooked but clinically decisive entity

open access: yesJournal of the Indian Academy of Geriatrics, 2022
Orthostatic hypotension (OH) is defined as a drop of >20 mm Hg of systolic or >10 mm Hg of diastolic blood pressure (BP) within 3 min of standing from lying position. It is a common geriatric syndrome caused by impaired orthostatic response of BP.
Gunja Jain   +3 more
doaj   +1 more source

The management of orthostatic hypotension in Parkinson's disease

open access: yesFrontiers in Neurology, 2013
Orthostatic hypotension is a common and disabling symptom affecting Parkinson’s disease (PD) patients. We present the effect of the different therapies commonly used to manage Parkinson’s disease on this clinical manifestation.
Alvaro eSanchez-Ferro   +2 more
doaj   +1 more source

First‐in‐human safety, tolerability, pharmacokinetics and pilot food‐effect study of the candidate antimalarial compound MMV367

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aim To evaluate the safety, tolerability and pharmacokinetics in healthy participants of orally administered MMV367 (GSK3772701), a novel antimalarial interfering with Plasmodium falciparum acyl coenzyme A synthetase 10/11 function. Methods This first‐in‐human study enrolled 47 healthy male and female participants.
Andrea Kuemmerle   +13 more
wiley   +2 more sources

Home - About - Disclaimer - Privacy